Pancreatic Cancer Research

ResearcherUniversity of Electronic Science and Technology of ChinaActive in the last 2 years

Deyuan Zhong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9197-3507; OpenAlex author ID A5084080931. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 4

  1. Integrative multi-omics reveal a CD4⁺ T cell-derived six-gene signature linking the immune-stromal ecosystem to prognosis and immunotherapy selection in pancre… Co-author DOI 10.1186/s12885-026-15613-2↗
  2. Dendritic cell-related gene signature in pancreatic cancer stratifies patient subtypes and implicates a KCTD14-TNF signaling axis. Co-author DOI 10.3389/fimmu.2025.1665906↗
  3. Intraoperative electron beam radiotherapy combined with gemcitabine and PD-L1 inhibitors for unresectable pancreatic cancer: Report of 3 cases. Co-author DOI 10.1016/j.asjsur.2024.10.050↗
  4. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fgene.2022.848391↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuxin Liang · 4 shared papers, 2022–2026 · strength 0.99
  2. Xiaolun Huang · 2 shared papers, 2024–2025 · strength 0.56
  3. Xiaolun Huang · 2 shared papers, 2022–2026 · strength 0.43
  4. Zilong Zhang · 2 shared papers, 2022–2025 · strength 0.39
  5. Yahui Chen · 1 shared paper, 2025 · strength 0.25
  6. Jin Shang · 1 shared paper, 2022 · strength 0.15
  7. Yutong Yao · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.